Stephen Wright
50Patents
26h-index
67Co-inventors
91Inventor score
Filing activity: Oct 2, 1986 → Apr 23, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9474726B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 69 | Active |
| US9066920B2 | Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy | Human Necessities | 69 | Active |
| US9956185B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 64 | Active |
| US9956186B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 63 | Active |
| US9956183B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 63 | Active |
| US9956184B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 62 | Active |
| US10111840B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 62 | Active |
| US9522123B2 | Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy | Human Necessities | 59 | Active |
| US10092525B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 58 | Active |
| US9949937B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 58 | Active |
| US10137095B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 58 | Active |
| US9949936B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 50 | Active |
| US10918608B2 | Use of cannabidiol in the treatment of epilepsy | Human Necessities | 45 | Active |
| US10709671B2 | Use of cannabinoids in the treatment of epilepsy | Performing Operations; Transporting | 45 | Active |
| US10603288B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 44 | Active |
| US10849860B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 44 | Active |
| US10709674B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 44 | Active |
| US10966939B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 43 | Active |
| US11065209B2 | Use of cannabidiol in the treatment of epilepsy | Human Necessities | 39 | Active |
| US11154516B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 38 | Active |
| US11096905B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 38 | Active |
| US11154517B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 34 | Active |
| US8790719B2 | Phytocannabinoids in the treatment of cancer | Human Necessities | 33 | Active |
| US10765643B2 | Use of cannabidiol in the treatment of epilepsy | Human Necessities | 31 | Active |
| US10583096B2 | Use of cannabinoids in the treatment of epilepsy | Human Necessities | 30 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.